Similar articles

• Osteosclerotic and osteolytic manifestations of hyperparathyroidism in a case of Tc99m SestaMIBI positive parathyroid adenoma.

  Das KJ, Sehgal AK, Jaiman A, Sethi RS. Das KJ, et al. Indian J Nucl Med. 2015 Jul-Sep;30(3):263-5. doi: 10.4103/0972-3919.158541. Indian J Nucl Med. 2015. PMID: 26170573 Free PMC article.
• Multiple Osteosclerotic Lesions: ARare Presentation of Hyperparathyroidism Secondary to Hypovitaminosis D.

  Idrees SM, Khan M, Humayun M, Khan WM, Anwar MS, Naveed S. Idrees SM, et al. J Coll Physicians Surg Pak. 2017 Sep;27(9):S80-S81. J Coll Physicians Surg Pak. 2017. PMID: 28969731
• Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.

  Jehle PM, Ostertag A, Schulten K, Schulz W, Jehle DR, Stracke S, Fiedler R, Deuber HJ, Keller F, Boehm BO, Baylink DJ, Mohan S. Jehle PM, et al. Kidney Int. 2000 Feb;57(2):423-36. doi: 10.1046/j.1523-1755.2000.00862.x. Kidney Int. 2000. PMID: 10652019
• The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part IV of IV parts: The state of the bones in uremic hyperaparathyroidism--the mechanisms of skeletal resistance to PTH in renal failure and pseudohypoparathyroidism and the role of PTH in osteoporosis, osteopetrosis, and osteofluorosis.

  Parfitt AM. Parfitt AM. Metabolism. 1976 Oct;25(10):1157-88. doi: 10.1016/0026-0495(76)90024-x. Metabolism. 1976. PMID: 787723 Review.
• Multiple myeloma associated with diffuse osteosclerotic bone lesions: a clinical entity distinct from osteosclerotic myeloma (POEMS syndrome).

  Lacy MQ, Gertz MA, Hanson CA, Inwards DJ, Kyle RA. Lacy MQ, et al. Am J Hematol. 1997 Dec;56(4):288-93. doi: 10.1002/(sici)1096-8652(199712)56:4<288::aid-ajh16>3.0.co;2-5. Am J Hematol. 1997. PMID: 9395194 Review.